Incident Score: Analysis & Impact (TAK1780684206)
The details regarding individual company incidents & reports gives you full view from every side.
Rankiteo Score Impact Analysis
Key Highlights From The Incident Analysis
- Timeline of TAKEDA PHARMACEUTICALS AMERICA, INC.'s Breach and lateral movement inside company's environment.
- Overview of affected data sets, including SSNs and PHI, and why they materially increase incident severity.
- How Rankiteo’s incident engine converts technical details into a normalized incident score.
- How this cyber incident impacts TAKEDA PHARMACEUTICALS AMERICA, INC. Rankiteo cyber scoring and cyber rating.
- Rankiteo’s MITRE ATT&CK correlation analysis for this incident, with associated confidence level.
Full Incident Analysis Transcript
In this Rankiteo incident briefing, we review the TAKEDA PHARMACEUTICALS AMERICA, INC. breach identified under incident ID TAK1780684206.
The analysis begins with a detailed overview of TAKEDA PHARMACEUTICALS AMERICA, INC.'s information like the linkedin page: https://www.linkedin.com/company/takeda-pharmaceuticals-america-inc., the number of followers: 6911, the industry type: Pharmaceutical Manufacturing and the number of employees: 635 employees
After the initial compromise, the video explains how Rankiteo's incident engine converts technical details into a normalized incident score. The incident score before the incident was 756 and after the incident was 691 with a difference of -65 which is could be a good indicator of the severity and impact of the incident.
In the next step of the video, we will analyze in more details the incident and the impact it had on TAKEDA PHARMACEUTICALS AMERICA, INC. and their customers.
On 02 June 2026, Takeda Pharmaceuticals USA, Inc. disclosed Data Breach issues under the banner "Takeda Pharmaceuticals USA Credential-Based Data Breach".
Shamis & Gentile P.A.
The disruption is felt across the environment, and exposing Personally Identifiable Information (PII).
In response, teams activated the incident response plan, moved swiftly to contain the threat with measures like Incident contained on detection, and stakeholders are being briefed through Notifications to Attorney General offices.
The case underscores how Concluded.
Finally, we try to match the incident with the MITRE ATT&CK framework to see if there is any correlation between the incident and the MITRE ATT&CK framework.
The MITRE ATT&CK framework is a knowledge base of techniques and sub-techniques that are used to describe the tactics and procedures of cyber adversaries. It is a powerful tool for understanding the threat landscape and for developing effective defense strategies.
MITRE ATT&CK® Correlation Analysis
Rankiteo's analysis has identified several MITRE ATT&CK tactics and techniques associated with this incident, each with varying levels of confidence based on available evidence. Under the Initial Access tactic, the analysis identified Valid Accounts (T1078) with high confidence (90%), supported by evidence indicating compromise of an employee’s credentials by an unauthorized third party. Under the Credential Access tactic, the analysis identified Brute Force (T1110) with moderate confidence (50%), supported by evidence indicating compromised credentials (no specific method mentioned) and Unsecured Credentials: Credentials In Files (T1552.001) with lower confidence (40%), supported by evidence indicating employee’s credentials compromised (implied storage weakness). Under the Discovery tactic, the analysis identified Account Discovery (T1087) with moderate to high confidence (70%), supported by evidence indicating unauthorized party accessed files containing PII and Data from Local System (T1005) with moderate to high confidence (80%), supported by evidence indicating files containing names, SSNs, medical records accessed. Under the Collection tactic, the analysis identified Data from Local System (T1005) with high confidence (90%), supported by evidence indicating sensitive data including names, SSNs, medical records exposed. Under the Exfiltration tactic, the analysis identified Exfiltration Over C2 Channel (T1041) with moderate to high confidence (70%), supported by evidence indicating unauthorized party may have accessed PII (implied exfiltration). Under the Impact tactic, the analysis identified Data Manipulation: Stored Data Manipulation (T1565.001) with lower confidence (30%), supported by evidence indicating no evidence of data manipulation, but PII was accessed and Data Destruction (T1485) with lower confidence (20%), supported by evidence indicating no evidence of data destruction, but breach occurred. These correlations help security teams understand the attack chain and develop appropriate defensive measures based on the observed tactics and techniques.
Sources & References
- TAKEDA PHARMACEUTICALS AMERICA, INC. Rankiteo Cyber Incident Details: https://www.rankiteo.com/company/takeda-pharmaceuticals-america-inc./incident/TAK1780684206
- TAKEDA PHARMACEUTICALS AMERICA, INC. CyberSecurity Rating page: https://www.rankiteo.com/company/takeda-pharmaceuticals-america-inc.
- TAKEDA PHARMACEUTICALS AMERICA, INC. Rankiteo Cyber Incident Blog Article: https://blog.rankiteo.com/tak1780684206-takeda-pharmaceuticals-usa-inc-breach-february-2026/
- TAKEDA PHARMACEUTICALS AMERICA, INC. CyberSecurity Score History: https://www.rankiteo.com/company/takeda-pharmaceuticals-america-inc./history
- TAKEDA PHARMACEUTICALS AMERICA, INC. CyberSecurity Incident Source: https://www.claimdepot.com/investigations/takeda-pharmaceuticals-data-breach-2026
- Rankiteo A.I CyberSecurity Rating methodology: https://www.rankiteo.com/Images/rankiteo_algo.pdf
- Rankiteo TPRM Scoring methodology: https://static.rankiteo.com/model/rankiteo_tprm_methodology.pdf